Balyasny Asset Management’s Elanco Animal Health ELAN Stock Holding History

Balyasny Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,000	Closed	-$263K	–	2956
2025 Q1	$263K	Hold	25,000	–	–	﹤0.01%	2502
2024 Q4	$303K	Hold	25,000	–	–	﹤0.01%	2380
2024 Q3	$367K	Buy	+25,000	New	+$348K	﹤0.01%	2396
2023 Q3	–	Sell	-780,000	Closed	-$7.85M	–	2369
2023 Q2	$7.85M	Buy	+780,000	New	+$7.24M	0.02%	883
2022 Q4	–	Sell	-200,000	Closed	-$2.48M	–	2890
2022 Q3	$2.48M	Buy	+200,000	New	+$3.5M	0.01%	1383
2021 Q2	–	Sell	-100,000	Closed	-$2.94M	–	2059
2021 Q1	$2.94M	Buy	+100,000	New	+$3.08M	0.01%	893

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Balyasny Asset Management's ELAN Position: Q1 2026 in Review

Balyasny Asset Management sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 1,086,098 shares — an estimated $24.6M sold.

Balyasny Asset Management first reported a position in ELAN in Q4 2018 and held it in 25 quarters. The position peaked at $112M in Q2 2023. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Balyasny Asset Management reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
Balyasny Asset Management sold 1,086,098 Elanco Animal Health shares in Q1 2026, an estimated $24.6M.
Balyasny Asset Management first reported a position in Elanco Animal Health in Q4 2018 and held it in 25 quarters.
Balyasny Asset Management's Elanco Animal Health position peaked at $112M in Q2 2023.
516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.